News
Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, reversing 2025’s fast ...
Ammonite was discovered using the Subaru Telescope in Hawaii, with follow-up confirmation from the Canada-France-Hawaii ...
Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...
Ryan Richardson joined BioNTech in 2018 and has served as Chief Strategy Officer since January 2020. During his time at the Company, he contributed significantly to BioNTech’s successful development, ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.
NextShark Ventures is proud to welcome Remission Biotech as the latest addition to its portfolio of companies redefining the ...
The FTC and DOJ's new approach to mergers and acquisitions could disrupt Utah’s dynamic life sciences ecosystem.
Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.
Despite promising science, Precigen has long-faced severe financial challenges and a very short cash runway into 2026. Click ...
NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...
Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results